Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial

IMPORTANCE: The GeparOcto randomized clinical trial compared the efficacy of 2 neoadjuvant breast cancer (BC) treatment regimens: sequential intense dose-dense epirubicin, paclitaxel, and cyclophosphamide (iddEPC) vs weekly paclitaxel and nonpegylated liposomal doxorubicin (PM) in patients with diff...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Oncol
Главные авторы: Pohl-Rescigno, Esther, Hauke, Jan, Loibl, Sibylle, Möbus, Volker, Denkert, Carsten, Fasching, Peter A., Kayali, Mohamad, Ernst, Corinna, Weber-Lassalle, Nana, Hanusch, Claus, Tesch, Hans, Müller, Volkmar, Altmüller, Janine, Thiele, Holger, Untch, Michael, Lübbe, Kristina, Nürnberg, Peter, Rhiem, Kerstin, Furlanetto, Jenny, Lederer, Bianca, Jackisch, Christian, Nekljudova, Valentina, Schmutzler, Rita K., Schneeweiss, Andreas, Hahnen, Eric
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2020
Предметы:
Brief Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7068666/
https://ncbi.nlm.nih.gov/pubmed/32163106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.0007
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы